Vitiligo Clinical Trial
Center for Dermatology Clinical Research in Fremont, CA is conducting a new clinical study evaluating a new investigational treatment option for vitiligo. There is no placebo. Compensation is available for qualified participants of this clinical research opportunity sponsored by Teva Pharmaceuticals.
Study Overview
Who Qualifies? Male or female patients ages 18-75 with vitiligo
Study Duration: 24 weeks + 1 year followup
Protocol: TV53408-IMM-10209